Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

M. Groevdal; R. Kahn; M. Jansson; A. Aggerholm; P. Antunovic; Jan Astermark; P. Bernell; L. Engstroem; L. Kjeldsen; O. Linder; L. Nilsson; A. Olsson; M. Skovholm; J. Tangen

doi:10.1016/S0145-2126(09)70069-4

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

M. Groevdal, R. Kahn, M. Jansson, A. Aggerholm, P. Antunovic, Jan Astermark, P. Bernell, L. Engstroem, L. Kjeldsen, O. Linder, L. Nilsson, A. Olsson, M. Skovholm, J. Tangen

Klinisk koagulationsmedicin, Malmö

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Originalspråk	engelska
Sidor (från-till)	S49-S50
Tidskrift	Leukemia Research
Volym	33
Nummer	Suppl 1
DOI	https://doi.org/10.1016/S0145-2126(09)70069-4
Status	Published - 2009
Evenemang	10th International Symposium on Myelodysplastic Syndromes - Patras, Grekland Varaktighet: 2009 maj 6 → 2009 maj 9

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1016/S0145-2126(09)70069-4

Citera det här

Groevdal, M., Kahn, R., Jansson, M., Aggerholm, A., Antunovic, P., Astermark, J., Bernell, P., Engstroem, L., Kjeldsen, L., Linder, O., Nilsson, L., Olsson, A., Skovholm, M., & Tangen, J. (2009). Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy. Leukemia Research, 33(Suppl 1), S49-S50. https://doi.org/10.1016/S0145-2126(09)70069-4

@article{84ef21537faf4fbaa4b8d6514420c27c,

title = "Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy",

author = "M. Groevdal and R. Kahn and M. Jansson and A. Aggerholm and P. Antunovic and Jan Astermark and P. Bernell and L. Engstroem and L. Kjeldsen and O. Linder and L. Nilsson and A. Olsson and M. Skovholm and J. Tangen",

year = "2009",

doi = "10.1016/S0145-2126(09)70069-4",

language = "English",

volume = "33",

pages = "S49--S50",

journal = "Leukemia Research",

issn = "1873-5835",

publisher = "Elsevier",

number = "Suppl 1",

note = "10th International Symposium on Myelodysplastic Syndromes ; Conference date: 06-05-2009 Through 09-05-2009",

}

Groevdal, M, Kahn, R, Jansson, M, Aggerholm, A, Antunovic, P, Astermark, J, Bernell, P, Engstroem, L, Kjeldsen, L, Linder, O, Nilsson, L, Olsson, A, Skovholm, M & Tangen, J 2009, 'Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy', Leukemia Research, vol. 33, nr. Suppl 1, s. S49-S50. https://doi.org/10.1016/S0145-2126(09)70069-4

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy. / Groevdal, M.; Kahn, R.; Jansson, M. et al.
I: Leukemia Research, Vol. 33, Nr. Suppl 1, 2009, s. S49-S50.

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

TY - JOUR

T1 - Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

AU - Groevdal, M.

AU - Kahn, R.

AU - Jansson, M.

AU - Aggerholm, A.

AU - Antunovic, P.

AU - Astermark, Jan

AU - Bernell, P.

AU - Engstroem, L.

AU - Kjeldsen, L.

AU - Linder, O.

AU - Nilsson, L.

AU - Olsson, A.

AU - Skovholm, M.

AU - Tangen, J.

PY - 2009

Y1 - 2009

U2 - 10.1016/S0145-2126(09)70069-4

DO - 10.1016/S0145-2126(09)70069-4

M3 - Published meeting abstract

SN - 1873-5835

VL - 33

SP - S49-S50

JO - Leukemia Research

JF - Leukemia Research

IS - Suppl 1

T2 - 10th International Symposium on Myelodysplastic Syndromes

Y2 - 6 May 2009 through 9 May 2009

ER -